ACIP | Home | Advisory Committee on Immunization Practices | CDC

ACIP | Home | Advisory Committee on Immunization Practices | CDC

ACIP Votes, October 2016

• ACIP approved the following four recommendations by majority vote on October 19, 2016:
  • Hepatitis B vaccine: birth dose within 24 hours of birth for medically stable infants weighing ≥2000 grams and born to HBsAg-negative mothers; removal of permissive language to delay the hepatitis B birth dose; approve revised statement.
  • Human papillomavirus vaccine: 2-dose schedule for boys and girls initiating HPV vaccination series at 9 to 14 years (0,6-12 months); 3-dose schedule for persons initiating HPV vaccination series at older ages; 3-dose schedule for immunocompromised persons.
  • Meningococcal vaccines: provided guidance on the updated dosing schedules for one serogroup B meningococcal vaccine, MenB-FHbp (Trumenba). For persons at increased risk for meningococcal disease and during serogroup B outbreaks, 3 doses of MenB-FHbp administered at 0, 1-2, and 6 months; when given to healthy adolescents not at increased risk for meningococcal disease, 2 doses of MenB-FHbp at 0 and 6 months.
  • Pertussis-containing vaccines: approve the updated statement, “Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the ACIP.”
• The 2017 Child/Adolescent and Adult Immunization schedules were approved by majority vote on October 20, 2016.
• If approved by the CDC Director, the recommendations will become official once published in MMWR.

ACIP Meetings

• Meeting Information Recent ACIP meeting agendas, detailed meeting minutes, live meetings, and presentation slides.
• Upcoming Meetings List of scheduled ACIP meeting dates.
• Register for a Meeting Next meeting's registration details including deadline, driving directions and hotel choices.

Immunization Schedules

View current schedules for children, teens, and adults.